Literature DB >> 181324

Effect of passive antibody on parainfluenza virus type 3 pneumonia in hamsters.

W P Glezen, G W Fernald.   

Abstract

Both parainfluenza virus type 3 and respiratory syncytial virus may produce life-threatening pneumonia or bronchiolitis in infants less than 6 months old. Almost all infants in this age group possess passively acquired maternal antibodies to both viruses. It has been suggested that maternal antibodies may actually participate in the pathogenesis of these diseases in early infancy. This investigation examined the effect of moderate levels of passive antibody on the development of pneumonia in hamsters infected intranasally with parainfluenza virus type 3. The pneumonitis produced in this model was not enhanced by the presence of moderate levels of serum antibody to this virus. Furthermore, reinfection after an initial "sensitizing" infection under the cover of passive antibody did not result in a more severe pneumonitis. These studies do not support either of the two hypotheses that have been advanced to explain the pathogenesis of infections with respiratory syncytial virus in early infancy.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 181324      PMCID: PMC420865          DOI: 10.1128/iai.14.1.212-216.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  SEROLOGICAL STUDY OF RESPIRATORY SYNCYTIAL VIRUS INFECTIONS IN INFANCY AND CHILDHOOD.

Authors:  P S GARDNER; F M ELDERKIN; A H WALL
Journal:  Br Med J       Date:  1964-12-19

2.  PARAINFLUENZA TYPE 3 VIRUS INFECTION IN HAMSTERS: VIROLOGIC, SEROLOGIC, AND PATHOLOGIC STUDIES.

Authors:  D A BUTHALA; M G SORET
Journal:  J Infect Dis       Date:  1964-06       Impact factor: 5.226

3.  ACUTE RESPIRATORY DISEASE IN INFANCY AND CHILDHOOD: PRESENT UNDERSTANDING AND PROSPECTS FOR PREVENTION.

Authors:  R M CHANOCK; R H PARROTT
Journal:  Pediatrics       Date:  1965-07       Impact factor: 7.124

4.  Effect of Sabin Type 1 poliomyelitis vaccine administered by mouth to newborn infants.

Authors:  M L LEPOW; R J WARREN; N GRAY; V G INGRAM; F C ROBBINS
Journal:  N Engl J Med       Date:  1961-05-25       Impact factor: 91.245

5.  Infection of hamsters with para influenza 3 virus.

Authors:  J E CRAIGHEAD; M K COOK; R M CHANOCK
Journal:  Proc Soc Exp Biol Med       Date:  1960-06

6.  Studies in experimental immunology of influenza. X. Passive immunity and its enhancement.

Authors:  S F DE ST. GROTH; D M GRAHAM
Journal:  Aust J Exp Biol Med Sci       Date:  1954-06

7.  Influence of immunological factors in respiratory syncytial virus disease.

Authors:  R M Chanock; A Z Kapikian; J Mills; H W Kim; R H Parrott
Journal:  Arch Environ Health       Date:  1970-09

8.  Viruses, Mycoplasma pneumoniae and bacteria associated with lower respiratory tract disease among infants.

Authors:  M A Mufson; H E Krause; H E Mocega; F W Dawson
Journal:  Am J Epidemiol       Date:  1970-02       Impact factor: 4.897

9.  Studies on the pathogenesis of parainfluenza type 3 virus infection in hamsters.

Authors:  C Liu; E Sharp; J Collins
Journal:  Arch Gesamte Virusforsch       Date:  1968

10.  Observations on clinical and immunofluorescent diagnosis of parainfluenza virus infections.

Authors:  P S Gardner; J McQuillin; R McGuckin; R K Ditchburn
Journal:  Br Med J       Date:  1971-04-03
View more
  3 in total

1.  Pathogenesis of human parainfluenza virus 3 infection in two species of cotton rats: Sigmodon hispidus develops bronchiolitis, while Sigmodon fulviventer develops interstitial pneumonia.

Authors:  D D Porter; G A Prince; V G Hemming; H G Porter
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

Review 2.  Biology of parainfluenza viruses.

Authors:  R Vainionpää; T Hyypiä
Journal:  Clin Microbiol Rev       Date:  1994-04       Impact factor: 26.132

3.  Nonspecific suppressive effect of bovine herpesvirus type 1 on bovine leukocyte functions.

Authors:  L G Filion; R L McGuire; L A Babiuk
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.